Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Abdollahi E, Moghadas SM, Galvani AP, The synergy of therapeutic vaccination and timely diagnosis for TB control in high-burden settings: Nunavut as a case study, Journal of Clinical Tuberculosis and other Mycobacterial Diseases 2025, 41: 100569.
Wells CR, Shoukat A, Shin T, Galvani AP, Moghadas SM, Racial and ethnic disparities in meningococcal vaccination coverage and disease burden among U.S. adolescents, Journal of Adolescent Health 2025 (in press).
Krylov SN, Krylova SM, Le ATH, Moghadas SM, Mawani A, Tabatabaei N, Papagelis M, Tsasis P, Wiktorowicz ME, Rosenbaum RS, A policy roadmap for sustainable mass-testing, Health Affairs Scholar 2025, 3(8): qxaf151.
Fitzpatrick MC, Wells CR, Pandey A, Ayaz L, Singer BH, Hotez PJ, Moghadas SM, Galvani AP, School-level gaps in MMR coverage as the fuel for measles outbreaks, Annals of Internal Medicine 2025, 1-3, 10.7326/ANNALS-25-01611.
Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Shi C, Ferreira SC, Maia HP, Moghadas SM, The impact of information dissemination and behavioural responses on epidemic dynamics: A multi-layer network analysis, Infectious Disease Modelling 2025, 10: 960-978.
Sumsuzzman D Md, Ye Y, Wang Z, Pandey A, Langley JM, Galvani AP, Moghadas SM, Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: A global systematic review and meta-analysis, BMC Infectious Diseases 2025, 25, 215.
Shi C, Ferreira SC, Maia HP, Moghadas SM, Examining heterogeneity in information diffusion and its impact on disease spread in a multilayer network, Trends in Biomathematics – Springer 2025, 259-273.
Shoukat A, Wells CR, Shin T, Potter-Schwartz L, Galvani AP, Moghadas SM, Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: A modelling study, The Lancet Regional Health – Americas 2025, 44: 101033.
Ye Y, Pandey A, Bawden C, Sumsuzzman D MD, Rajput R, Shoukat A, Singer BH, Moghadas SM, Galvani AP, Integrating artificial intelligence with mechanistic epidemiological modeling: A scoping review of opportunities and challenges, Nature Communications 2025, 16(1): 1-18